.cms-textAlign-left{text-align:left;}.cms-textAlign-center{text-align:center;}.cms-textAlign-right{text-align:right;}.cms-magazineStyles-smallCaps{font-variant:small-caps;}
The Food and Drug Administration on Thursday authorized a second antiviral pill for people infected with Covid as the Biden administration works to ease the burden on hospitals swamped with patients during this most recent surge.
The agency is only authorizing Merck’s pill, called molnupiravir, for people who test positive, are at high risk for severe disease and are at least 18 years old. FDA said Thursday that the pill can’t be used by patients younger than 18 because it “may affect bone and cartilage growth.”
The agency also warned against
→ Continue reading at Politico
